ICOTINIB-CONTAINING TOPICAL SKIN PHARMACEUTICAL COMPOSITION AND USE THEREOF
    2.
    发明公开
    ICOTINIB-CONTAINING TOPICAL SKIN PHARMACEUTICAL COMPOSITION AND USE THEREOF 审中-公开
    ICOTINIBHALTIGE药物组合物,外用对皮肤及其用途

    公开(公告)号:EP3056206A1

    公开(公告)日:2016-08-17

    申请号:EP14851908.5

    申请日:2014-10-11

    摘要: Disclosed are topical preparations for inhibiting tyrosine kinase and preparation methods thereof, and especially topical pharmaceutical compositions for inhibiting tyrosine kinase and preparation methods thereof. The active ingredient of the topical preparations is Icotinib or a pharmaceutically acceptable salt thereof. The preparations are suitable for topical application, with minimal skin irritation, no adverse reactions such as pruritus, burning sensations, tingling, dry skin, erythema and rashes, without parahormone-related side effects such as skin atrophy, pigmentation or hypopigmentation for long-term use, as well as no related dermatological symptoms after drug withdrawal. The preparation methods are easily understood, operable, and controllable, and are suitable for industry mass production.

    摘要翻译: 本发明公开了局部制剂用于抑制酪氨酸激酶及其制备方法,和爱尤其局部用药物组合物用于抑制酪氨酸激酶及其制备方法。 局部制剂中的活性成分是埃克替尼或其药学上可接受的盐。 制剂为适合局部施用,以最小的皮肤刺激,无不良反应:如瘙痒,烧灼感,麻刺感,皮肤干燥,红斑和皮疹,无需对激素相关的副作用:如皮肤萎缩,色素沉着或色素沉着不足的长期 使用,以及停药后没有相关的皮肤症状。 制备方法很容易理解的,可互操作的,可控,并且适用于工业大批量生产。